Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Church architecture Stories

2012-12-24 04:20:23

LONDON, December 24, 2012 /PRNewswire/ -- It has been announced that the Architects' Forum 2013 will be devoting an entire day to glass and glazing specifically targeting the role of the material in modern architecture. The team at MDM Glass [http://www.mdmglass.co.uk ] are excited about the prospect of what next year's forum proposes to share about the future of glass in domestic and commercial spaces. Glass has become one of the most prominent features of modern cities...

2012-05-09 02:25:52

POINT RICHMOND, Calif., May 9, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that Transcept management is scheduled to present at two upcoming investor conferences. Transcept management plans to present a general corporate overview at the: JMP Securities Research...

2012-05-07 10:24:51

POINT RICHMOND, Calif., May 7, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company will host a conference call on Monday, May 14, 2012, at 4:30 p.m. Eastern Time to discuss its first quarter 2012 financial results. The conference call will follow the release of the...

2012-04-10 10:24:25

POINT RICHMOND, Calif., April 10, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today the appointment of Thomas Soloway to the position of Executive Vice President and Chief Operating Officer. (Logo: http://photos.prnewswire.com/prnh/20101102/SF93452LOGO) "Tom has played a key and...

2012-02-29 07:03:00

POINT RICHMOND, Calif., Feb. 29, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that Transcept management is scheduled to present at two investor conferences in March 2012. Transcept management plans to present a general corporate overview at the: Cowen Health Care...

2012-02-07 07:05:00

POINT RICHMOND, Calif., Feb. 7, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that Transcept management is scheduled to present at two upcoming investor conferences. Transcept management plans to present a general corporate overview at the: <blockquote> BIO CEO and...

2011-12-08 15:05:00

POINT RICHMOND, Calif., Dec. 8, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that Transcept management is scheduled to present at the Oppenheimer & Co. Healthcare Conference in New York on December 13, 2011 at 10:15 a.m. ET. <font size="2"...

2011-11-02 06:45:00

POINT RICHMOND, Calif., Nov. 2, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company will host a conference call on Thursday, November 10, 2011 at 4:30 p.m. Eastern Time to discuss its third quarter 2011 financial results. The conference call will follow the release...

2011-10-24 15:05:00

POINT RICHMOND, Calif., Oct. 24, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that Transcept management is scheduled to present at the BIO Investor Forum in San Francisco on October 26, 2011 at 9:30 a.m. PT. A live audio webcast and replay of this presentation may be...

2011-08-04 15:35:00

POINT RICHMOND, Calif., Aug. 4, 2011 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company will host a conference call on Thursday, August 11, 2011 at 4:30 p.m. Eastern Time to discuss its second quarter 2011 financial results. The conference call will follow the release...